⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. ZYNLONTA® (loncastuximab tesirine-lpyl) | For 3L DLBCL just got measured.
5/10 means ZYNLONTA® (loncastuximab tesirine-lpyl) | For 3L DLBCL is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
ZYNLONTA® (loncastuximab tesirine-lpyl) is a 3L treatment for relapsed or refractory diffuse large B-cell lymphoma. See Full Prescribing Information.
Industry: Healthcare
zynlontahcp.com2
Structured Data
7
Content Structure
7
Entity Clarity
2
E-E-A-T Signals
6
Technical AEO
3
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for ZYNLONTA® (loncastuximab tesirine-lpyl) | For 3L DLBCL.
Scored by Engagemii on July 6, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/zynlontahcp
Cite this score: Engagemii (2026). "AEO Score for ZYNLONTA® (loncastuximab tesirine-lpyl) | For 3L DLBCL." Retrieved from https://engagemii.com/aeo/brands/zynlontahcp
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform